Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Grant/Award of 75,000 CVKD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Grant/Award | 75,000 | n/a |
| Apr 6, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 829 | $56.4K |
| Mar 9, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 10,000 | $633.8K |
| Feb 20, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 2,484 | $172.3K |
| Jan 12, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 866 | $66.2K |
| Jan 8, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 1,340 | $103.1K |
| Jan 6, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Grant/Award | 18,750 | n/a |
| Dec 4, 2025 | Cadrenal Therapeutics, Inc. (CVKD) | Grant/Award | 5,000 | n/a |
| Apr 4, 2025 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 897 | $42.1K |
| Feb 21, 2025 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 795 | $39.8K |